Press Releases
ICU Medical, Inc. Announces Time of Third Quarter 2021 Earnings Conference Call
October 13, 2021
SAN CLEMENTE, Calif. , Oct. 13, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its third quarter 2021 earnings release and
ICU Medical, Inc. to acquire Smiths Medical division from Smiths Group plc for $2.35 billion in cash and stock plus the assumption of certain liabilities and a stock price performance-based earn-out
September 8, 2021
The addition of Smiths Medical syringe and ambulatory infusion devices, vascular access, and vital care products into ICU Medical creates a leading infusion therapy company with a stronger global reach Complementary product portfolios joined to create a leading IV therapy company and simplify
ICU Medical Issues a Voluntary Nationwide Recall of Aminosyn II 15%, An Amino Acid Injection, Sulfite Free IV Solution Due to the Presence of Particulate Matter
September 3, 2021
FOR IMMEDIATE RELEASE – September 3, 2021 LAKE FOREST, Illinois – ICU Medical, Inc. is voluntarily recalling one lot (2,112 units) of Aminosyn II, 15%, An Amino Acid Injection, Sulfite Free intravenous (IV) solution to the hospital/user level due to the presence of visible particulate matter
ICU Medical, Inc. Announces Second Quarter 2021 Results
August 4, 2021
Company Updated FY 2021 Guidance SAN CLEMENTE, Calif. , Aug. 04, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for
ICU Medical, Inc. Announces Time of Second Quarter 2021 Earnings Conference Call
July 15, 2021
SAN CLEMENTE, Calif. , July 15, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its second quarter 2021 earnings release
ICU Medical, Inc. Announces First Quarter 2021 Results
May 6, 2021
SAN CLEMENTE, Calif. , May 06, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for the quarter ended March 31, 2021 .
ICU Medical, Inc. Announces Time of First Quarter 2021 Earnings Conference Call
April 15, 2021
SAN CLEMENTE, Calif. , April 15, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its first quarter 2021 earnings release
ICU Medical, Inc. to Participate in Fireside Chat at the KeyBanc Life Sciences & MedTech Investor Forum
March 18, 2021
SAN CLEMENTE, Calif. , March 18, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will participate in a virtual
ICU Medical, Inc. Announces Fourth Quarter 2020 Results and Provides Fiscal Year 2021 Guidance
February 25, 2021
SAN CLEMENTE, Calif. , Feb. 25, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for the quarter ended December 31,
ICU Medical, Inc. to Present at the Raymond James 42nd Annual Institutional Investors Conference
February 24, 2021
SAN CLEMENTE, Calif. , Feb. 24, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the Raymond
Displaying 1 - 10 of 12